Abstract: Current strategies in pharmaceutical research comprise two methodologically different but complementary approaches for lead finding purposes, namely the random screening of compound libraries and the structure-based effort, commonly termed rational drug design. The structurebased approach is aimed to exploit 3D structure data of the molecular components involved in the molecular recognition event that underlies the attempt to therapeutically modulate the biological function of a macromolecular target with proven pathophysiological relevance for a disease state.
Introduction
extracellularly occurring receptor-ligand recognition event is transferred through conformational rearrangements within the transmembrane portion of the receptor protein to the intracellular compartment. Upon this ligand-induced receptor activation, a multistep cascade of signal transduction events is initiated depending on the very nature of the distinct member of the GPCR family recognizing its ligand in a highly specific manner [3, 4] (Fig. (1 ) ).
Among transmembrane proteins of current biomedical interest (table 1) , the G protein-coupled receptors (GPCRs) constitute a superfamily of transmembrane receptor proteins that establish a functional and unidirectional link between the exterior of a cell and its cytoplasm [1, 2] . The information of an A broad spectrum of chemically diverse endogenous, as well as exogenous ligands, ranging from cations, biogenic monoamines, fragrances and Obviously, nature has designed a highly efficient transmembrane signal transduction system in that the great variety of receptor agonists (table 2) converges towards the same type of target receptors, while the Fig. (1) . Schematic presentation of the sequentially occurring signal transduction events initiated upon extracellular ligand binding (1.) to the G protein-coupled receptor. The transmembrane receptor protein (2. ) is composed of seven α helices, spanning the membrane as a helix bundle. A selection of activated effector systems (3.) and of the subsequently released second messengers (4.) is shown.
Fig. (2).
A representative ensemble of GPCR ligands is shown in a Connolly surface mode in order to highlight the broad range of molecular size, spread by the chemically diverse set of ligands.
diversity is retained, since ligand-specific signalling cascades are triggered upon GPCR activation. From a pharmaceutical research point of view, GPCRs represent one of the most prominent classes of validated drug targets. According to a survey from 1995, 22% of the one hundred world-wide top-selling prescription drugs exert their therapeutic effect by targeting distinct receptors from the GPCR family [5] , while the ratio referenced to all approved drugs reaches even 50 -60% [6] . In terms of sales, GPCRtargeted drugs created a market potential that was estimated to approximately 84 billion US $ in 1995 [7] ! A more detailed analysis of GPCRs, currently targeted by released drugs, reveals a strong bias in favour of the classical neurotransmitter receptors, such as the 5-HT, histamine, muscarinic acetylcholine, dopamine, or the noradrenaline receptor (table 3) .
protein was deduced. The putative binding site within the protein was mapped by mutational studies, while the key interactions, governing the corresponding molecular recognition event, were determined following classical comparative analyses on series of congeneric low-molecular weight compounds. These studies succeeded to demonstrate that site-directed mutations on the receptor protein were complemented by the tailor-made modification on the ligand molecule, thereby supporting the structural hypothesis underlying the interaction model shown in Fig. ( 3 ) [15, 16] .
Comparing the target-receptor distribution profile of released GPCR-targeted drugs with the number of identified receptors that can be attributed as therapeutically relevant target systems, a significant imbalance becomes immediately apparent, thus demanding future pharmaceutical research to focus on e.g. peptide-binding GPCRs [8, 9] .
Consequently, the numerous biogenic monoamine agonists and antagonists are accommodated by the same binding pocket in the target protein and can be envisioned as classical competitive modulators.
Referring to the pharmacodynamic and -kinetic problems, generally associated with the chemical nature of peptides, modern medicinal chemistry will make extensive use of well-established peptidomimetic concepts to approach this goal following a ligandguided philosophy [10] [11] [12] .
As mentioned above, the comprehensive screening programs conducted over the last years mostly in pharmaceutical industry uncovered for almost any peptide-binding GPCR non-peptide, low-molecular weight ligands, the majority being antagonists [13, 14] (scheme 1).
A complementary approach, relying on random or directed screening of diverse or targeted compound libraries, uncovered already numerous non-peptide leads for peptide-binding GPCRs, interestingly most of them act as antagonists [13, 14] .
From mutational mapping increasing evidence emerged that almost all peptide agonists interact with sequentially discontinuous epitopes on the extracellular surface of the transmembrane protein, while the non-peptide antagonists seem to address receptor residues further inward along the normal of
Binding Site Ambiguity
For the biogenic monoamines, a consensus binding mode within the transmembrane portion of the receptor the membrane surface [8] . The antagonists obviously penetrate the seven-helix bundle, all GPCRs are believed to be composed of, and probably populate a biogenic monoamine-related binding site (Fig. (3 ) ).
Concluding, agonists and antagonists of peptidebinding GPCRs do not address the same "lock", even though some antagonists turned out to competitively displace the native ligand. In this context, the model of allosteric competitive antagonism is discussed in literature [8, 17] . The hypothesis of two spatially separated, not even overlapping binding sites for agonists and antagonists is further corroborated by the results of numerous diverse research projects on both molecular interaction partners, the receptor protein and the ligands, respectively. By constructing chimeric receptors it could be shown that the exchange of extracellular portions of the receptor protein allowed a directed shift of agonist-specificity, while non-peptide antagonist-binding was retained [8] . Even the complete deletion of a huge extracellular domain of e.g. metabotropic glutamate receptors (mGluRs), proven to be responsible for agonist (glutamate) binding [19, 20] , yielded a receptor construct that could functionally be activated by non-peptide compounds [21] . In an elegant protein-engineering approach, a Zn 2+ binding site was introduced into the neurokinin-1 receptor by replacing selected transmembrane residues against metal ion-coordinating histidines [8, 22] . These mutations did not affect native ligand binding, but spatially interfered with a non-peptide antagonist (CP-96,345) binding site, thus completely abolishing antagonist binding [8, 22] .
From the viewpoint of an educated medicinal chemist it appears apparent that most non-peptide antagonists fail to display any meaningful structural resemblance to the corresponding peptide agonist, thus further accounting for non-overlapping binding sites. Although the attempt of constructing a structural relation between non-peptide antagonists and peptide agonists is claimed for e.g. the biphenyl-tetrazole drugs and angiotensin II [23] , close examination of the entire body of available data on that system clearly defeats the hypothesis of a common and overlapping pharmacophore arrangement [24] . A naturally occurring mutant of the human angiotensin II receptor from Xenopus laevis turned out to bind the native ligand with unaltered affinity, while the binding of the biphenyltetrazole drugs could not be detected. This observation is a clear evidence for the intact, surfaceexposed AII binding epitope, obviously being spatially separated from the non-peptide antagonist pocket, the latter being modified in the Xenopus laevis receptor, yielding a receptor protein, no longer capable of antagonist binding [25] .
multitude of different sources, finally yielding a 3D model by a template-assisted approach. Resulting structure models are energetically relaxed by a specially developed molecular mechanics set-up, explicitly accounting for the anisotropic environment of the receptor protein.
It should further be noted that although a remarkable diversity is displayed by the non-peptide antagonists of peptide-binding GPCRs (scheme 1), inherently reflecting the different origins of these compounds (in-house stocks, combinatorial chemistryderived libraries, natural products), highly redundant structural elements can be identified among antagonists targeting different receptors (scheme 2).
The concluding perspective will summarise the potential applicability of GPCR models within the context of current medicinal chemistry research, clearly defining the limitations of these models.
This review is not intended to duplicate the excellent papers on GPCR modeling that appeared over the last years [27] [28] [29] [30] [31] [32] [33] , instead it is attempted to reflect the current state of derived structure knowledge on 7TM proteins and the underlying methodologies. Further, an integrated modeling approach is proposed attempting to account for the entire body of structurally relevant data principally available for a GPCR of interest.
These frequently recurring privileged substructures support a further idea, namely the existence of a binding pocket within the transmembrane domain, obviously highly conserved throughout the entire family of GPCRs that might correspond to the delineated binding site within the biogenic monoamine receptors [26] (Fig. (3 ) ).
Structural Investigations on 7TM Proteins
The hypotheses on binding sites and binding modes of GPCR ligands discussed above clearly demand the design of further experiments that help to gain more detailed insights into the binding event of agonists and antagonists to their corresponding receptors. A 3D structure framework could serve as a common platform for "asking new and intelligent questions".
Rhodopsins constitute a family of integral membrane proteins containing a retinal molecule (vitamin A aldehyde) covalently bound through a Schiffbase linkage to the ε-NH 2 group of a lysine residue that is located approximately halfway between the cytoplasmic and extracellular surfaces of the protein.
Members of these photoactive pigments fall into two distinct subfamilies, the prokaryotic and eukaryotic rhodopsins, respectively [34, 35] . Prokaryotic rhodopsins function as light-driven proton pumps (bacteriorhodopsin, archaerhodopsins), light-driven chloride ion pumps (halorhodopsin), and photosensors, mediating photoattractant as well as photophobic responses. In contrast, eukaryotic rhodopsins are G protein-coupled receptors acting as visual pigments in initiating the visual excitation cascade upon absorption of light. The structurally unifying paradigm among all rhodopsins is a widely conserved protein topology characterised by seven sequentially consecutive transmembrane stretches that adopt α helical conformations, linked by extracellular and intracellular loop regions with an extracellular N-and an intracellular C-terminus [36] . Despite these common structural principle, the prokaryotic rhodopsins definitely do not belong to the family of GPCRs, as indicated by a low sequence homology between e.g. bacteriorhodopsin and the visual pigments or other GPCRs of approximately 10% to 15%. Thus, the 3D structure of prokaryotic rhodopsins such as bacteriorhodopsin or halorhodopsin cannot simply be accepted as a structural framework for molecular modeling attempts aiming at GPCR structure models. This review is intended to address the different concepts for deriving structurally relevant information on GPCRs, focussing on the latest developments from biophysical studies on 7TM proteins. In the following, diffraction studies on a distinct member of the 7TM protein family, i.e. bacteriorhodopsin, are discussed, since this protein turned out to serve as the working horse for the development of new methodologies for crystallisation and structural investigation of transmembrane helix-bundle proteins. As a light-driven proton pump, bacteriorhodopsin, as well as further prokaryotic 7TM proteins, clearly cannot be envisioned as representatives of the GPCR class, however, their investigation certainly sets the stage for ongoing and future structural research on GPCRs. The current state of experimentally derived structure data on further rhodopsins will be highlighted in order to elaborate the significant differences between the prokaryotic rhodopsins and GPCR structures.
A new integrated GPCR modeling approach will be introduced making extensive use of thorough sequence analysis tools for deriving 1D, 2D, and 3D structure data on GPCRs. The procedure follows a hierarchical scheme interfacing information from a
Structure
Studies on Prokaryotic Rhodopsins the in-plane dimensions and decreased resolution in the vertical direction [42] . In relation to x-ray diffraction, electron microscopy-based imaging and diffraction has different capabilities. While in x-ray crystallography the beam is scattered by the electron cloud of the molecule, atomic scattering factors for electron diffraction are more complex. The electrons interact with the Coulombic potential that arises from the negatively charged electron cloud, as well as from the positively charged nuclei. Therefore, electron form factors (atomic electron scattering cross-sections) are more sensitive to the physicochemistry of atoms, such as the nature of chemical bonding, ionised functionalities, or polarised, partially charged groups. One advantage of electron crystallographic structure determination over x-ray crystallography is that phase information, often a major obstacle in x-ray-based structure determination, is available from images taken with the electron microscope [41, 42] .
Undoubtedly, bacteriorhodopsin is by far the best characterised 7TM protein not only in terms of function, but also from a structural point of view. At the beginning of the 70's, the chromoprotein was found to form large 2D crystalline sheets of purple membrane in Halobacterium salinarium in vivo [37] . The fundamental observation that bacteriorhodopsin can be induced to form large and stable 2D crystals set the stage for all following structure determination efforts on 7TM proteins for the next 20 years to come. The first milestone was set by Henderson and Unwin describing a 7 Å resolution map of purple membrane obtained from electron microscopy and electron diffraction techniques in 1975 [38] . Even though this pioneering work dates back almost 25 years, the first 3D structure of bacteriorhodopsin with atomic resolution comparable to that of soluble proteins was described only recently [39] . This breakthrough became possible by a novel crystallisation strategy yielding 3D crystals of sufficient diffractive quality for synchrotron studies [40] . Selected studies from the history of bacteriorhodopsin structure investigations will be highlighted in the following, initially introducing the electron microscopic and crystallographic studies on 2D crystals, followed by a brief survey on lipidic phases utilized to obtain 3D crystals. Finally, the high resolution, x-ray derived structure of bacteriorhodopsin will be discussed.
As mentioned above, the task of 3D structure determination of bacteriorhodopsin was initiated by Henderson and Unwin in 1975 with the publication of their first electron microscopical study on a purple membrane preparation from Halobacterium halobium [38] . From the prepared 2D crystals which formed oval sheets with 1 µm in diameter and 45 Å thickness, different 2D views were recorded referring to the method of tilted specimen. These allowed to construct a 3D map of the electric potential inside the membrane at 7.0 Å resolution (in-plane). With the assumption that the strict physical quantity derived from electron scattering, namely the Coulombic potential is proportional to the electron density and atomic number, at least at that low resolution, the first structural insights into a 7TM protein were derived. The resulting 3D map was described as dominated by numerous "rod-shaped features" aligned perpendicular to the membrane surface [38] . Within each asymmetric unit seven rods, packed 10 Å to 12 Å apart, form a molecule with overall dimensions of 25 Å x 35 Å x 40 Å (x x y x z, z being perpendicular to the membrane plane). All rods span a distance of 35 Å to 40 Å along their main axis, perfectly corresponding to the thickness of the 2D crystal. Each protein molecule contributes to a trimeric bundle with a threefold symmetry axis aligning a lipid bilayer-filled hole of 20 Å diameter in the centre of the trimeric bundle [38] . From that time on, the rods were assumed to represent the seven transmembrane α helices forming the 7TM domain of retinal proteins. From the underlying experimental data collected by electron microscopy and electron diffraction, the covalently linked retinal chromophore could not be resolved.
Structure Studies on 2D Crystals of Bacteriorhodopsin
Since 3D crystallisation followed by x-ray structure determination were not achievable until recently, the vast majority of structure studies on 7TM proteins utilised electron microscopy in combination with computational image processing on 2D crystals. A 2D crystal is a highly ordered, single-layered crystalline specimen of small thickness (with vertical unit-cell dimension), obtained by detergent-mediated reconstitution of solubilised and purified protein into bilayers, closely resembling a native, membrane-like environment [41] . Within these planar lattices that occur as vesicles, sheets, or tubes, repetitive subunits of identical composition appear in equivalent positions with a high degree of symmetry, being the precondition for extracting information on structural details by electron microscopy and diffractive techniques [42] . Although the information on structural details is not visible on the primary image, computational processing techniques in combination with electron diffraction patterns enhance structural details to almost atomic resolution. Practically, a series of projections obtained with different tilt angles are combined to produce a 3D image of the investigated system with high resolution in 3D structure studies on bacteriorhodopsin were steadily pursued at the MRC, Cambridge and the group around Henderson made remarkable progress at the end of the 80's in that they succeeded to build an atomic model structure of bacteriorhodopsin, again based on experimental findings from electron diffraction patterns and electron cryo-microscopy [43] . At that time, a more detailed picture on the functional details of the light-driven proton pump was already drawn, facilitating the cross-fertilisation of both, structural and functional studies.
At this improved resolution, the formerly assigned "rod-shaped features" [38] appear to display finestructured surface properties allowing to identify bulky aromatic sidechains of e.g. phenylalanine, tyrosine, and tryptophane residues. These surface features were used as guide points for aligning the protein sequence onto the experimental densities, further facilitating the structure refinement process [43] . It is noteworthy that in this study the retinal molecule was clearly visible, especially the β-ionone ring could be identified in its binding pocket within the 7TM domain. The chromophore is covalently bound to the ε-NH 2 group of Lys-216 and governs the gating of the proton pump by its isomerisational switch. The Schiff-base forms a kind of bottom of two half-channels protruding from the centre of the helix bundle towards the extracellular and intracellular surface, respectively. The residues delineating both half-channels could clearly
The structure model, released as 1BRD in the Brookhaven Protein Data Bank was based on the potential map derived from 72 images of tilted specimen recorded at the temperature of liquid helium [43] . Combining electron cryo-microscopically derived micrographs and electron diffraction patterns allowed to drive the resolution of the resulting projection map up to 3.5 Å in the membrane plane and 7.8 Å perpendicular to the membrane surface [43] . be identified from the experimental data and were further assumed to contribute specifically to the molecular mechanism of the ion transport process. The channel leading to the extracellular surface appears somewhat wider and hydrophilic when compared to the cytoplasmic half-channel [43] .
of the chromophore. In general, the extracellular portion of the protein exhibits a higher degree of order when compared to the more flexible cytoplasmic side. Interestingly, ten distinct lipid molecules associated to the exterior of the 7TM domain could partially be resolved and were included into the released coordinate set [44] (Fig. (4 ) ). By expanding the available experimental data set by 30 additional images of tilted specimen, thus contributing phase information to the density map, the resolution could further be enhanced from 7.8 Å (1BRD) to 4.3 Å (2BRD) in the vertical dimension [44] ( Fig. (4 ) ). Apart from the first extracellular and the first and third intracellular loops which show no interpretable density, the entire protein is visible. Interesting structural details became obvious with this refined structure which went undetected or were even misinterpreted in the precursor structure. In this context, transmembrane helix 4 had to be altered with respect to the initially released model by a 4 Å shift towards the cytoplasm (Fig. (5 ) ). From the improved experimental data, resolved densities were observable accounting not only for aromatic sidechains, but also for leucine, isoleucine, valine, and threonine residues. Further it turned out that transmembrane helices 2, 3, and 6 show an overall kinked shape due to proline residues near the centre of the helical stretches (Pro-50, Pro-91, Pro-186). A thorough analysis of temperature factor profiles revealed numerous interesting details about the dynamical characteristics of protein portions. The most ordered parts are residues of helices 4 and 6, aligning the β-ionone ring A further high-resolution electron crystallography study on bacteriorhodopsin appeared recently [45] . The derived data even allowed to improve the in-plane resolution further up to 3.0 Å (1AT9), thereby revealing new structural details, especially an improved surface structure of the transmembrane protein. While in 2BRD three loops were assigned as disordered, in the latest study of a japanese group all loops are shown to be highly structured [45] . The first extracellular loop even adopts a two-stranded antiparallel β-sheet structure (Fig. (6 ) ). With the refinement of the aqueous solventaccessible surface area of the transmembrane protein, new features, probably driving the transport mechanism, became apparent. The cytoplasmic entry into the 7TM domain is dominated by four aspartic acid residues aligned in a plane that might function as a gate, providing access to the cytoplasmic half-channel. On the extracellular surface, four glutamic acid residues terminate the trans-protein pathway of the proton [45] .
Apart from studies on bacteriorhodopsin, much effort has been spent on the structure elucidation of the light-driven chloride-ion pump halorhodopsin from Halobium salinarium. Summarising these efforts, the Fig. (5) . Side-by-side stereo picture of the overlaid helices 4 of 1BRD (C atoms in yellow) and 2BRD (C atoms in grey), respectively. In order to highlight the vertical shift of helix 4 when comparing both structures, the superposition was achieved by selecting the backbone atoms of helices 1, 2, 3, 5, 6, and 7 as reference atoms. groups around Henderson at the MRC, Cambridge and around Oesterhelt at the Max-Planck-Institute for Biochemistry, Munich, succeeded to produce 3D structures applying essentially identical techniques as described above. As net result from a series of investigations, the projected structure of halorhodopsin seems to be almost identical to that derived for bacteriorhodopsin, thus reflecting the close sequential relation between these proteins [46, 47] . new and efficient strategies for crystallisation of these entities within their native environment.
Lipid Membrane Morphology: Cubic Phases
The molecular components of lipid-rich bioaggregates such as membranes display a remarkable physicochemical heterogeneity in that they adopt various different lyotropic liquid crystalline states or mesophases, the degree of order residing between the purely liquid and the crystalline solid state [50] [51] [52] . Depending on the aggregation state adopted by the membrane lipids, lamellar structures, forming multilayer aggregates that are found in e.g. different gel phases, are generally distinguished from non-lamellar architectures such as hexagonal and cubic phases [50] [51] [52] . The appearance of cubic phases is further classified into the closed micellar phase consisting of distinct micelles, and the bicontinuous cubic phase exhibiting a curved continuous bilayer architecture of cubic symmetry (Fig. (7 ) ). This complex 3D lipidic array is pervaded by an intercommunicating aqueous channel system creating a symmetric liquid crystalline structure with sufficient long range order in all spatial dimensions [48, 49, 52] . This bicontinuous lipidic cubic phase was shown to be an ideal matrix for providing nucleation sites for initial crystal formation and further facilitates crystal growth due to the still disordered acyl chains of the lipids allowing for a lateral diffusion of the transmembrane protein within the curved bilayer structure [48, 49] . This "seeding and feeding" mechanism within a membrane matrix of sufficient 3D regularity is the precondition to obtain crystalline material amenable to experimental structure determination by diffractive techniques. Apart from adopting a highly structured 3D array, the bicontinuous lipidic cubic phase displays further characteristics advantageous for biophysical studies, since it is optically isotropic, transparent and highly viscous [48, 49, 52] .
Structure Studies on 3D Crystals of Bacteriorhodopsin
At the end of 1996, Landau and Rosenbusch published their promising results on obtaining 3D mircrocrystals of bacteriorhodopsin [48, 49] utilising a new concept of membrane protein crystallisation from 3D membrane-mimetic matrices, afforded by a distinct morphological state of lipid membranes, notably the lipidic cubic phases [50] [51] [52] . Soon after that report, the 3D structure of bacteriorhodopsin was refined to 2.5 Å and deposited in the Brookhaven Protein Data Bank (entry code 1AP9) [39] . Prior to a brief survey on the new structural details revealed by that high-resolution structure of bacteriorhodopsin, a few remarks on the morphology of lipid membranes with special emphasis laid on the characteristics of quasi-solid lipidic cubic phases will be made in order to underline the relevance of that significant progress made in membrane protein structure determination. Again, using bacteriorhodopsin as a working horse, a new enabling technology was established that might mark a quantum leap forward in membrane protein crystallisation, thus opening the route to an increase in quality and quantity of integral membrane protein structures. Even though new 3D structures of proteins are released at an almost breath-taking rate (app. 100 structures each week [53] ), the family of membrane proteins is entirely underrepresented in this expanding realm of biomolecular structure knowledge, thus demanding Having the concept of lipidic cubic phases as crystallisation matrix for membrane proteins established, the group at the Biozentrum in Basel succeeded to obtain microcrystals of bacteriorhodopsin as tiny and fragile hexagonal plates with typical dimensions of 20 to 40 µm x 20 to 40 µm x 5 µm [48, 49] . The crystals based on a monoolein cubic phase were flash-frozen to 100 K and required a highly intense microfocus x-ray beamline for the diffraction experiments, which were finally carried out at the European Synchrotron Radiation Facility (ESFR) in Grenoble [39] . The 3D structure of bacteriorhodopsin was solved at a resolution of 2.5 Å by molecular replacement, using the results from Henderson's electron crystallographically derived structure models discussed above [39, 44] .
parameters different from the cubic phase-derived crystals. Depending on the performance of the synchrotron facility used, the obtained crystals diffract x-rays beyond 2.5 Å resolution [54] .
High-Resolution X-ray Structure of Bacteriorhodopsin
The crystals obtained from the bicontinuous lipidic cubic phases were composed of stacked layers of 2D sheets of bacteriorhodopsin trimers, similar to the topology found in naturally occurring 2D crystals. The overall packing is relatively dense with 62% of the volume occupied by protein, while the remainder is accommodated for water and lipids with almost equal distribution [38, 48, 49] . A further elegant example of governing lipid phase changes for the purpose of producing 3D crystals of membrane-inserted proteins used bacteriorhodopsin as the probe protein [54] . In this study, 3D crystals of hexagonal geometry were obtained by a two-step change in membrane morphology. Starting with 2D crystals of bacteriorhodopsin in its native lipidic environment, i.e. the purple membrane, a phase transition was induced by treatment with neutral detergent and precipitant yielding uniform spherical vesicles with a diameter of app. 50 nm. A further controlled increase in precipitant concentration at low temperatures produced optically isotropic hexagonal crystals that grew upon successive fusion of the vesicular assemblies [54] . Preliminary x-ray diffraction data collected at the synchrotron facilities in Tskuba and Harima (Japan) reveal a space group and unit cell The major refinement of the bacteriorhodopsin structure achieved by the x-ray study clearly refers to the enhanced spatial resolution along the main helix axis of the seven α helices constituting the 7TM domain. The 2.5 Å structure closely resembles the structural details elaborated over two decades by electron microscopy, image reconstruction, and electron crystallography on 2D crystals. However, distinct differences can be found in loop conformations and in the orientation of sidechains from selected residues. The first intracellular as well as the first extracellular loop differ most remarkably from previously discussed structures. One of the most challenging insights achieved from that x-ray study is the location of several protein-bound water molecules relaying hydrogen-bond networks between key residues of the assumed proton-pumping pathway [39, 55] . Due to the well resolved positions of functionally important amino acid sidechains, together with the precise position of interacting water molecules presumably participating in the proton transport, a high resolution picture of a likely proton pathway emerged from that study. The more interested reader is referred to the original literature [39] , since a detailed discussion of the transfer pathway and the numerous associated functional states of bacteriorhodopsin constituting the entire photocycle is clearly beyond the scope of that contribution.
based on electron cryo-microscopy, image processing, and electron crystallographic studies of 2D crystals with steadily increasing spatial resolution. Projection structures of bovine rhodopsin [57] , frog rhodopsin [58] , and squid rhodopsin [59] were calculated at resolutions that clearly allow to define the topological differences between GPCRs on one hand and bacterio-and halorhodopsin on the other hand.
The history of structural elucidation of eukaryotic rhodopsins is different from that of bacteriorhodopsin in that it is characterised by a steady interplay between experimental structure studies on receptor proteins from different vertebrate and invertebrate sources. Even though no high resolution structure is available, a prototype 3D structure model for the 7TM domain of the rhodopsin family of GPCRs was deduced from an iterative structure refinement procedure, permanently interfacing structural bioinformatics studies conducted by Joyce Baldwin [60, 61] into the structure reconstruction attempts, mainly carried out at the MRC in Cambridge, UK.
Inspired from that pioneering study, only 9 months after the x-ray structure of bacteriorhodopsin was published [39] , a further structure with slightly improved resolution (2.3 Å) was solved by taking advantage of the very same crystallisation technology employing cubic phases [56] . In this study, the authors observed an unexpected C 2 symmetry, presumably due to twinned crystals, which was explicitly accounted for within the refinement strategy. Apart from a different number of localised water molecules aligning the proton-conducting pathway, the overall structure reproduces the findings derived earlier. As in 1AP9 [39] , the newly released structure 1BRX [56] does not show any interpretable density for the N-(1-5) and Ctermini (229-248), respectively. Also parts of the third cytoplasmic loop (154-166) are obviously disordered.
Structure Studies on 2D Crystals of the Rhodopsin GPCRs
The first projection structure of bovine rhodopsin with an in-plane resolution of 9 Å was published in 1993 [57] . In this study, rhodopsin was purified form bovine rod outer segments and reconstituted into lipid bilayers yielding 2D crystals of sufficient size and quality for an electron cryo-microscopic investigation. The resulting projection density map revealed interesting details on the arrangement of the transmembrane helices. The density map displays an arc-shaped feature in proximity to four resolved peaks of density (Fig.(8 ) ). While the arc-shaped density was assigned to three tilted or kinked helices with overlapping termini in the projection plane, the four resolved peaks were interpreted as four helices oriented perpendicularly in the membrane. Since no structure data were collected from tilted specimen, only 2D structure information in terms of the projection map emerged from that investigation [57] .
Structure

Studies on Eukaryotic Rhodopsins
Unlike the rhodopsins from bacterial sources, the eukaryotic rhodopsins belong to the protein superfamily of GPCRs, thus qualifying them as ideal candidates to derive experimental structure data indicative for that target family, since these proteins also tend to form 2D crystals amenable to electron microscopy and crystallography methods. In contrast to the bacterial rhodopsins that function as ion pumps, eukaryotic rhodopsins are visual pigments that trigger a signal transduction cascade upon light absorption through cytoplasmic G protein-coupling in the outer segment of rod cells of the vertebrate retina, thereby inducing membrane hyperpolarization and nerve excitation [34, 35] . Comparative protein sequence analyses reveal amino acid sequence homology of eukaryotic rhodopsins with several members of the GPCR family, supporting not only the functional relation between rhodopsins and GPCRs, but also suggesting that the numerous members of that pharmacologically interesting target family are structurally related to the rhodopsins.
Structure Data Meet Sequence Data
Two weeks after the manuscript on the projection structure of bovine rhodopsin was submitted for publication, Joyce Baldwin submitted a paper on the tentative structure of the transmembrane domain of GPCRs [60] . Structural implications for the 7TM domain are extracted from a thorough comparative sequence analysis study and combined in an elegant way with the experimentally derived structure data on bovine rhodopsin discussed above [57] . Distinct features in Currently, no high resolution structure derived from x-ray crystallography on 3D crystals is available for any GPCR protein. However, a huge body of structurally relevant data were derived over the last few years Fig. (8) . Density map of bovine rhodopsin derived from electron cryo-microscopy studies, revealing an arc-shaped density peak and four resolved density maxima. A detailed description of the biophysical studies on rhodopsins can be found on the internet pages from the [60] . From this multiple alignment strategy a "fingerprint" was deduced identifying highly conserved patterns in the primary structure of the 7TM domain (scheme 3). Based on that sequence pattern, the putative transmembrane sequence stretches spanning the hydrophobic core of the bilayer membrane were assigned under the following assumptions:
• four residues flank the 18 core residues on the extracellular and the cytoplasmic surface, respectively.
These qualitative, 1D structure data were expanded to 2D structure information by imposing the fingerprint onto helical wheels. This approach revealed helices 1, 4, 5, and 6 to display large surfaces with no polar residues, assigning them to be significantly exposed to the lipidic environment. Helices 2, 3, and 7 seem to be more buried, since their hydrophobic radial segments are definitely smaller [60] .
A more detailed consideration of sequence characteristics allowed for a clear discrimination of lipidfacing surface patches from helix contact areas and from the interior of the helix bundle. The assignment of residues oriented inward into the helix bundle was corroborated by the consideration of residues, identified to be involved in ligand binding from numerous mutagenesis studies. Finally, the distinct
• the 7TM domain is formed by ideal α helices, each consisting of 26 residues;
• 18 residues are required to span the hydrophobic core of the membrane, no polar or charged residues are expected to face the lipidic environment in that part of the sequence;
Helix I Helix II Helix III Helix IV Helix V Helix VI Helix VII helical wheels were assembled to a 7TM helix bundle, thus representing cross-sections of the receptor protein taken at different heights along the normal of the membrane. Helices 1, 4, and 5 were found to be exposed to the lipidic exterior, while helix 3 turned out to be well protected from the membrane environment. Additionally, the anticlockwise arrangement when viewed from the extracellular side (outside-in view) emerged as the most likely circular topology for GPCRs, since only this arrangement accounted for the majority of available mutagenesis and ligand binding data on GPCRs [60] . Summarising, valuable structural information could be deduced from a sequence analysis on approximately 200 GPCR sequences that yielded not only a rough assignment of the transmembrane sequence stretches, but also resulted in a 3D model, the characteristics of which turned out to be compatible with the low-resolution projection map of bovine rhodopsin [57] (Fig. (8 ) ). The structure model produced was capable to verify the experimental results on GPCRs at various levels of structural organisation, i.e. sequence segments were assigned to density peaks in the projection map, helical wheel analysis revealed the rotational orientation with respect to adjacent helices, and the assembly of the helical wheels proposed a spatial arrangement in three dimensions.
Enhanced
Resolution of Bovine Rhodopsin
In 1995, the group around Schertler at the MRC succeeded in improving the structural details of GPCRs, by combining micrographs taken from 2D crystals with different tilt angles [62] . After image processing a 3D structure could be obtained, still with poor vertical resolution. Due to the small size and disorder of the crystalline areas, an electron crystallographic investigation was prohibitive. However, from the cryo-microscopically derived 3D structure, four clearly resolved helices together with three remarkably tilted helices could be identified, clearly resembling the 3D model obtained from the GPCR sequence analysis discussed above [62] .
Only recently, researchers of the MRC were able to obtain crystals from bovine rhodopsin that were sufficient in size and order for structure elucidation by means of electron crystallography [63] . The horizontal resolution could be improved to 5 Å. The unit cell of the crystal lattice is formed by four alternating rhodopsin molecules. Helices 4, 6, and 7 are visible as isolated density peaks and seem to be inserted almost perpendicular into the membrane, while helices 1,2, and 3 are tilted and overlap in the projection. In contrast to the previously described low resolution structure [57, 62] , helix 5 significantly deviates from a perpendicular orientation [63] . transmembrane domain. In 1995, the frog rhodopsin structure obtained from two mutually different crystal forms, exhibiting an in-plane resolution of 6 Å, was reported [58] . From this enhanced resolution it became obvious that helix 5 was more tilted than anticipated from the very first study on the bovine protein. The density map at a resolution of 6 Å shows three resolved and isolated peaks in a triangular arrangement, accounting for helices 4, 6, and 7. The density of helix 4 is separated from that of helices 6 and 7 by a contiguous band of density extending through the centre of the molecule. This density feature arises from a series of tilted helices that are not sequentially arranged in a consecutive manner. For the final helix assignment, the authors interfaced the results from the exhaustive structural bioinformatics study from J. Baldwin [60, 61] .
Structure Studies on Frog Rhodopsin
The MRC group not only accumulated structure data on bovine rhodopsin [57, 62, 63] , but also worked on other vertebrate and invertebrate rhodopsins [58, 59, 64, 65] . The results obtained from microscopical and diffractive techniques on frog rhodopsin [58, 64] complement the work on the bovine receptor protein [57, 62, 63] , since structure data from the frog protein were available earlier and at higher resolution. Given a sequence identity between both proteins of 85 %, bovine and frog rhodopsin are assumed to share very similar, if not identical 3D structural features in the Fig. (9) . Schematic presentation of the reconstructed frog rhodopsin topology (left), derived from a stack of density maps taken from different heights along the membrane normal. The density maps (right) are shown in an inside-out view, revealing the clockwise arrangement of the seven transmembrane helices. The pictures can be obtained from the internet under the same address as given in the caption of Fig. (8 ) .
The most interesting finding from that study refers to the orientation of helix 5, which turns out to be in contact with helix 3 due to the pronounced inclination angle of the helix axis [58] .
The overall helix packing is more dense on the cytoplasmic surface and the helix bundle opens up ascending towards the extracellular side, thereby forming a cavity delineated by surface patches from helices 3, 4, 5, 6, and 7 accessible from the extracellular compartment. This is undoubtedly a finding of general interest for the entire family of GPCRs in terms of ligand binding capabilities [64] .
The MRC group reported on a further improved 3D structure of frog rhodopsin in 1997 that revealed more detailed structural insights into the seven helix bundle [64] (Fig. (9 ) ). The achieved resolution allowed to compute approximate tilt angles for all seven helices. The tilt angles for the three perpendicular helices 4, 6, and 7 range from 3.8° to 13.4°, while helices 1, 2, 3, and 5 display values between 22,7° and 30°, respectively. Due to the significant tilted insertion mode of four helices, the specific helix-helix interactions are not restricted to sequentially adjacent transmembrane sequence stretches. Also the degree of lipid exposure of distinct helices changes significantly along their pathways through the lipid bilayer (Fig. (9 ) ).
3D Structure Template for GPCRs
The steadily growing size of sequence databases together with the availability of projection maps of bovine [57, 62, 63] , frog [58, 64] , and squid [59] rhodopsins with dramatically improved resolution demanded an updated version of Baldwin's sequence/structure study on GPCRs of the rhodopsin family [60] . Consequently, Baldwin expanded her study to approximately 500 GPCR sequences and included further indirect structure data obtained from a series of biochemical studies on numerous GPCRs elaborated by different research groups [61] . It was the frog rhodopsin density map with considerably high resolution vertical to the membrane plane [58] , thus revealing a detailed picture of the distinct helix axes and tilt angles, that encouraged Baldwin and colleagues to generate a 3D model for a prototype GPCR. Based on the density maxima observable for all seven helices of frog rhodopsin in the corresponding projection map over a 20 Å axis perpendicular to the membrane plane (Fig. (9 ) ), the trace of each helix across the lipid bilayer could be reconstructed. From the density cross sections taken equidistantly from the computed 3D image of frog rhodopsin, a first atomic
The most tilted helix 3 is deeply buried in the protein, its cytoplasmic end being surrounded by helices 2, 4, 5, and 7. On its way to the extracellular surface the helix axis drifts away from helix 5. In the centre of the membrane, helix 3 is in close proximity to helix 7 establishing a "through-bundle" contact ( Fig.  (9 ) ).
Helix 4 seems to be the shortest and least tilted helix. On the extracellular side it makes contact with its sequential neighbours, notably helices 3 and 5, but descending to the intracellular side the interaction partners change due to their tilted orientation, i.e. helix 4 is in contact with helices 2 and 3. model was constructed consisting of the C α positions of each transmembrane amino acid adopting a helical conformation [66] . While the first qualitative model of GPCRs from 1993 was deduced from ideal helical wheels [60] , solely accounting for tilt angles of each helix, in the advanced model released in 1998 helix kinks induced by proline residues are included [66] . For helices 5 and 6 the occurrence of prolines in the transmembrane sequence stretches produces significant changes of the inclination angle relative to the normal of the membrane plane (table 4) . residues, was identified for large surface areas of helices 2, 3, and 7. From the model building procedure it became obvious that the membrane-water boundary not necessarily disrupts the helical conformation of the transmembrane sequences, reflected by the mutually different vertical extents of the helices (table 4) . Although an uncertainty remains for the assignment of the exact helix termini, some of them clearly protrude from the membrane surface into the flanking aqueous compartments [66] .
A thorough analysis of conservation patterns in the context of the generated 3D model even allowed to postulate defined interactions of conserved residues within spatially adjacent helices, contributing to the stability of the helix bundle. The final structure model was extensively verified against results from various protein engineering studies on different peptidebinding GPCRs, from chemical modification studies delineating the solvent accessible surface area of e.g. the dopamine D 2 receptor, and from numerous mutagenesis studies [66, and references therein].
According to the rules for transmembrane helix bundles referring to amphiphilicity, as well as conserved and variable sequence positions [67, 68] , the lipid-facing surface patches could be unambiguously identified. Together with the cross sections of the frog rhodopsin density map (Fig. (9 ) ), the orientation of each helix with respect to the centre of the bundle was clearly deducible (Fig (1 0 ) ).
Helices 1, 4, and 5 exhibit large lipid-facing surface areas displaying large sections of variable sequence positions. A high degree of conservation, being diagnostic for structural or functional important
The resulting C α template (Fig. (1 0 ) ) undoubtedly represents the most reliable structure scaffold available today for any homology modeling-related approach aimed to model distinct GPCR proteins.
residues while the bacterial receptor proteins contain approximately 250 residues, respectively. A sequence similarity search over protein sequence databases with vertebrate rhodopsins as queries uncovers numerous sequences of GPCRs to be homologous with significant sequence identity to the query. Using bacteriorhodopsin as query, almost no GPCR sequences are found with high similarity or identity scores.
To underline the relevance and broad applicability of the available 3D model, the following chapter will briefly highlight the most striking differences between GPCRs and bacteriorhodopsins, thus rendering any modeling attempt of GPCR structures employing the bacterial receptor protein structure highly questionable.
Structure Scaffolds: Bacteriorhodop-sin versus GPCRs
Although no structure of a vertebrate rhodopsin was determined at a comparable high resolution as for bacteriorhodopsin, several structural features were identified to be entirely different in both protein classes. In contrast to bacteriorhodopsins, almost all eukaryotic GPCRs form a highly conserved disulphide bond between the extracellular terminus of helix 3 and the second extracellular loop connecting helices 4 and 5 [36] . A comparable structural constraint is missing in bacteriorhodopsin. In general, membrane cross sections of the vertebrate rhodopsin structures are described to appear as compact entities, while the bacterial receptors exhibit an elongated helix bundle when projected into the membrane plane [62, 65] (Fig.  (1 1 )) . Also the pattern of tilt angles, i.e. deviation of the long axis from a perpendicular membrane-insertion mode, is significantly different when the projection map of bacteriorhodopsin is compared to either frog [58, 64] , squid [59] , or bovine [57, 62, 63] rhodopsin Fig. (1 1 ) . In the bacterial helix bundle, helices 2, 3, and 4 show an almost perpendicular arrangement, while the remaining helices overlap to form an extended arc shaped density trace [44] . In contrast, helices 4, 6, and 7 are oriented along the membrane normal in the eukaryotic receptor proteins, while helices 1, 2, 3, and
The majority of GPCR modeling attempts described in literature aimed to obtain 3D structure models of the 7TM domain for rationalising e.g. structure-activity relationships of low-molecular weight agonists and/or antagonists within the putative ligand binding pocket of the target receptor employed the coordinates of bacteriorhodopsin 1BRD as underlying structure scaffold [16] . This is certainly due to the availability of that coordinate set for the scientific community in the Brookhaven Protein Data Bank since 1990 [43] . On the light of the structural and functional knowledge on rhodopsins derived over the last years, rhodopsin structures from bacterial sources can no longer serve as templates to build GPCR structure models on. The most striking differences among prokaryotic and eukaryotic rhodopsins will be summarised briefly.
On the level of primary structure, no significant homology can be detected between bacteriorhodopsin and e.g. human rhodopsin, the vertebrate receptors comprise approximately 350 Fig. (11) . Left: Experimentally derived density maps of bovine rhodopsin (above) and bacteriorhodopsin (below). Right: Side-by-side stereo picture of the C α trace-model of vertebrate rhodopsins (above) compared to the x-ray-derived structure of bacteriorhodopsin (below, PDB entry code: 1AP9). The density maps, as well as the helix bundles are shown in an inside-out view. Fig. (12) . Geometric analysis of the 7TM domains of the Cα trace-model (top) and bacteriorhodopsin (1AP9, bottom). For defining the interhelical tilt angles ( θ) and the interhelical distances on the extracellular and cytoplasmic protein surfaces, two reference points were defined for each helix as the geometric mean of three consecutive Cα atoms of the corresponding helix termini.
5 partially overlap in an in-plane projection (Fig. (1 1 )) . Not only the tilt angle profile is dramatically different, but also the distribution of helix-distorting proline residues in the transmembrane helices shows an entirely unique pattern. Prolines are found in helices 2, 3, and 6 in the bacterial receptor, and in helices 4, 5, 6, and 7 in the vertebrate rhodopsins. The combination of the different membrane insertion modes and a different pattern of helix kinks clearly reveal the substantial differences of both receptor proteins. A more detailed and quantitative structural comparison of the C α template for rhodopsin-type GPCRs and the x-ray structure of bacteriorhodopsin is given with a geometric analysis in Fig. (1 2 ) .
Functionally, the bacterial proteins act as light-driven ion pumps, thus facilitating transport of matter through the transmembrane helix bundle, while eukaryotic rhodopsins work as switching moieties, transmitting a signal across the membrane. This functional difference is further reflected by the different ground states of the covalently bound cofactor, notably retinal. In bacteriorhodopsin the absorption of light triggers isomerisation of all-trans retinal to the 11-cis isomer, while in vertebrate rhodopsin the 11-cis isomer represents the ground state. The event of cis/trans isomerisation in bacteriorhodopsin can be compared with a channel-gating function, while in vertebrate rhodopsins the isomerisation only induces a conformational rearrangement in the receptor protein enabling cytoplasmic epitopes to couple to the G protein.
rhodopsin-type GPCRs discussed above, a new integrated receptor modeling approach is introduced in the following, taking advantage of the results obtained from the exhaustive sequence analyses, and of the structure template developed for the transmembrane domain of GPCRs, respectively [66] . The utilisation of these data is embedded in a hierarchical modeling procedure, relying on a new combination of especially developed structural bioinformatics tools, tailor-made homology modeling-related techniques, as well as molecular dynamics-based simulation protocols for structure refinement under explicit treatment of the anisotropic solvent environment. The basic steps of On the light of these pronounced structural differences between the ion-pump bacteriorhodopsin and the vertebrate rhodopsin GPCRs, one should refrain from employing any bacteriorhodopsin structure as underlying framework for GPCR modeling purposes.
Integrated GPCR Modeling Approach
To demonstrate the implications of the structure data derived from the biophysical studies on the Fig. (13) . The flowchart defines the distinct steps of the hierarchically organised integrated GPCR modeling procedure described in the text. the entire modeling procedure are schematically summarised in Fig. (1 3 ). template model generated by the MRC group [66] . With this implementation it becomes feasible to assign residues as being embedded in the hydrophobic core of the bilayer membrane and to determine the N-and Cterminal boundaries for each of the seven α helices forming the bundle. For that purpose, the query sequence is superimposed onto that extended fingerprint guided by the positions of highly conserved residues within the corresponding sequence stretches (scheme 3). At this stage, a differentiation between hydrophobic core residues, potential interface residues, and aqueous solvent-accessible residues can be made by application of a set of empirical rules derived for transmembrane helices, such as the positive-inside-rule [75] or the increased probability to find tryptophanes and tyrosines in the membrane interface area [68] . This preliminary differentiation yields a "1D topology" reflecting a qualitative partitioning of the linear protein sequence between the distinct environment compartments.
According to that hierarchical procedure, the protein sequence of a GPCR of interest is subjected to an exhaustive sequence similarity search conducted over all accessible sequence databases [69] by standard sequence analysis tools as implemented in software packages such as GCG (Wisconsin Genetics Computer Group [70] ). Depending on the resulting similarity profile, a multiple sequence alignment for e.g. the sequences from all subtypes of a given receptor and from all species are aligned in order to develop a more reliable picture of the receptor family-wide characteristics, rather than focussing on the query sequence alone (Fig. (1 4 ) ). The determination of consensus sequence patterns emerging from the multiple sequence alignment is further required for the conservation analysis carried out during the course of the modeling procedure. The multiple sequence alignment serves as basic data-set for the calculation of numerous different property profiles that are generated over the alignment following a sliding window strategy [71] . The comparative analysis of e.g. the polarity profile according to the parameters from Zimmerman [72] or Hopp and Woods [73] , or of the hydrophobicity profile according to Kyte and Doolittle [74] generated for the multiple sequence alignment allows to assign the putative transmembrane regions more specifically than plotting a single profile calculated for a single query sequence (Fig. (1 5 )) . Based on the 7TM fingerprint elaborated for the GPCR family by Baldwin [60, 61] (scheme 3), the resulting conservation pattern is extended in the current procedure by interfacing the available 3D structure information on rhodopsin-type GPCRs, in that the extracellular and cytoplasmic boundaries of the helices are now defined by the C α The multiple sequence alignment (Fig. (1 4 ) ) generated in the first step of the GPCR modeling procedure can optionally be used for periodicity analyses of various parameters such as hydrophobicity, polarity, variability, or conservation. Unfortunately, the applicability of that concept as implemented in PERSCAN [76] is severely limited. The entire philosophy of periodicity analyses is based on the assumption that the transmembrane domain is composed of a regular bundle of seven ideally folded α helices being aligned perpendicular to the membrane plane, all of them exhibiting ideal amphiphilic helix surface attributes. The rationale behind this type of analysis refers to the partitioning of physicochemical surface properties displayed by amphiphilic peptide helices, as well as to the protein architecture of α Fig. (14) . Selected section of a multiple sequence alignment of CCK-A and CCK-B receptor sequences from different species, only accounting for the seventh transmembrane sequence stretch. The identifiers preceding the amino acid sequence correspond to the SwissProt database entry codes. The notations e, c, and i below the alignment characterise extracellular (e) interface, core (c), and intracellular (i) interface residues; the extent of the corresponding helix from the Cα trace-model is given on the bottom line. Fig. (15) . The property profile derived from the multiple sequence alignment for CCK receptor helix 7 (Fig. ( 14) ), based on the Kyte-Doolittle and Zimmerman parameters clearly facilitates the identification of the helix boundaries.
helices, i.e. the periodicity of selected properties accounts for 3.6 residues per helical turn, thus representing the repetition frequency of the properties.
To circumvent the problems obviously associated with amphiphilicity and periodicity analyses, a helical wheel assembly step allows to identify the lipid-facing surface patches more reliably, since the helical wheels are superimposed on the peak maxima from the experimentally derived density maps of rhodopsins. The resulting "2D topology" provides a platform to rationalise highly conserved sequence positions in terms of structural and functional relevance and further allows to gain qualitative insights into possible helixhelix interactions. The 2D topology is a prerequisite receptor sequence representation, defining the interrelation between the family-wide sequence characteristics and the 3D structure template employed for initial coordinate assignment.
From the structure studies on eukaryotic rhodopsins it became apparent that (i) the bundle topology is far from being regular, (ii) the helices are kinked due to central proline residues, (iii) some helices are tilted and deviate from the perpendicular insertion mode, and (iv) the concept of amphiphilicity cannot be applied to the 7TM domain, due to the occurrence of buried and exposed helices. Therefore, periodicity analyses resulting in helical property moments projected onto helical wheels can only be employed to derive a preliminary picture of relative orientation of each helix within the context of the helix bundle.
In the subsequent step, a template-assisted model building procedure, based on the 3D coordinates of rhodopsin [66] is conducted to "explode" all previously derived sequence/structure relationships into the third dimension. Following a template forcing strategy, the seven distinct sequence stretches are harmonically forced onto the C α trace to yield an initial 3D structure model of the 7TM domain. The resulting bundle consists of seven individual helices and requires energetic relaxation in order to remove any intermolecular strain and unfavourable interatomic interactions caused by the model building procedure.
The limited applicability of helix property moments for defining the rotational in-plane orientation is demonstrated by an analysis of the corresponding vectors calculated for the experimentally derived 3D structure of bacteriorhodopsin (2BRD, Fig. (1 6 ) ). It is apparent that the main hydrophobicity moment of each helix does not necessarily define the centre of the lipidfacing helix surface. Further, the orientation of the main polarity moment vector tips significantly deviate from the centre of the helix bundle. For ideal transmembrane helices, both vectors should be aligned in a perfect antiparallel orientation.
For that purpose, the helix bundle is centred in a cubic box and subsequently soaked, thus yielding a tri- phasic solvent system consisting of the extracellular aqueous phase, a central hydrophobic membrane compartment, and the cytoplasmic aqueous phase (Fig. (1 7 ) ). standard loop generation strategies utilised for e.g. homology models of soluble proteins. The three surface loops on both membrane interfaces are mounted onto the helix termini in an entirely expanded conformation. The new structure is again soaked into the anisotropic solvent environment and subjected to a 100 ps MD simulation with the helix backbone atoms being restrained to their original position, as are the sidechain atoms of membrane core residues. The sidechains from interface residues are free to move since they are exposed to establish contacts to loop residues. During the simulation a distance restraint is active, accounting for the disulphide bond between the terminus of helix 3 and the second extracellular loop. The resulting structure is then submitted to a long-term molecular dynamics simulation at a temperature of 300 K while all restraints are gradually removed over the course of the simulation.
Even though the membrane-flanking aqueous compartments are represented by explicit water molecules, an explicit treatment of a phospholipid bilayer is still computationally prohibitive for routine applications. In this context, a computationally less demanding membrane mimetic is implemented, consisting of uncharged Lennard-Jones particles representing qualitatively the lipidic phase [77] .
The initially derived helix bundle structure is energetically relaxed following a short-time dynamics protocol that efficiently allows the entire system to remove any bad contacts in a native-like solvent environment. During a 100 ps molecular dynamics simulation with an especially tailored temperature profile, the C α atoms are weakly position-restrained in order to keep the overall topology close to the experimentally derived structure model.
The resulting structure is envisioned as a sufficiently relaxed model and can serve for the purpose of rationalising further experimental findings derived for the GPCR of interest, thus offering the opportunity to initiate an iterative validation and refinement procedure. In any case, it should be stressed that the derived model is a "zero-order" model and requires a quality After this initial relaxation, the loops are generated according to an algorithm, significantly different form assessment by evaluating experimentally derived findings in the context of that very structure by either attempting to rationalise mutagenesis data, structureactivity data on low-molecular weight compounds, or identifying possible binding modes of agonists and/or antagonists [78, 79] . available experimental input data can by no means be compared to classical homology models of soluble proteins such as e.g. proteases. They clearly lack the degree of spatial resolution and structural refinement necessary for giving an approximately correct picture of the atomic details that would be mandatory for e.g. structure-based drug design, not to mention the derivation of quantitative estimates governing the energetics of ligand-receptor interactions.
Conclusion and Perspective
In order to take precautions against any tendencies of overinterpreting the accuracy or predictive abilities of generated GPCR models, the author prefers to reflect his ideas of molecular models of GPCRs. Structural models of GPCRs based on the current state of However, like any structure emerging from a molecular modeling study, GPCR models are able to grip our imagination by enabling the researcher to visualise, animate, and manipulate the structure model in real-time. Fig. (18) . GPCR models serve as communication platforms, thus establishing an operational link between molecular biology studies and medicinal chemistry research aimed to find lead structures for GPCRs.
It is obvious that the emerging GPCR models will undoubtedly suffer in their quality from oversimplification, but, according to E. Schrödinger, "we can approach a complex understanding only when simple ideas that can be perceived by the human brain as a whole encompass the totality of what has been presented" [80] .
Even though currently derivable GPCR models are little more than simplified caricatures of the molecular species they allegedly portray, thus still being far from accurately reflecting reality, they are valuable, indispensable tools. And indeed, over the last few years, 3D structure models of GPCRs turned out to be qualified means to discuss findings from molecular biology and medicinal chemistry on a common platform, thereby providing an opportunity for a rapid exchange of mutually relevant information in a truly interdisciplinary manner (Fig. (18) ).
